Evidence from a regression discontinuity design
Jennifer Hutcheon, University of BC
Tuesday, June 15, 2021
12-1 pm PDT
Antenatal corticosteroids are a medication given to pregnant women at risk of preterm delivery to prevent breathing complications after birth in the newborn. Their use at late preterm gestational ages (34-36 weeks) is controversial because it is unclear whether the neonatal benefits outweigh their unknown potential to harm child neurodevelopment. This webinar will discuss how a regression discontinuity design can provide new insights into the safety of antenatal corticosteroid administration for longer-term child neurodevelopment.
Dr. Jennifer Hutcheon is an Associate Professor and Canada Research Chair in Perinatal Population Health in the Department of Obstetrics & Gynaecology at UBC. Her research uses large population health and administrative databases to inform best practices in the care of pregnant women and their infants. She received her PhD in Epidemiology & Biostatistics from McGill University.
This seminar will be conducted via Zoom. Please contact Joyce (firstname.lastname@example.org) for the link.